Tiny Biotech Firm Update

Buyers are strapping in for the ride of their lives… July 11, 2022 [UNSUBSCRIBE]( | [WEBSITE]( [Altucher Confidential] “Buy this stock at any price below $5. Then, sit on your hands.” [HERO IMAGE] Tiny Biotech Firm Update By Chris Campbell URGENT: Drug Stock Could End Arthritis? [Read more here...]( Will This Company’s Breakthrough Give New Hope To Millions? If You Or Somebody You Know Suffers From Arthritis, Pay Close Attention. [Click Here For All Of The Urgent Details.]( Good news. If you were looking for the understatement of the week, you’ve come to the right place: Biotech stocks have been in the dumps. The biotech-stock selloff has been so brutal that over 200 biotech companies have negative enterprise values, meaning that their liquid assets are worth more than their market values. Or, put a different way, their market cap is worth less than the cash they hold. Our colleague and biotech maven, Ray Blanco, said this about the recent biotech slump: “I’ve tracked the ups and downs in biotech going back 30 years, and the current biotech bear is the worst I’ve ever seen over the period.” Everyone hates biotech. Attention! Before You Read Any Further… [Click here for more...]( it’s James. Before you read any further in today’s issue, an urgent situation needs your immediate attention. If you don’t plan on claiming this upgrade to your Altucher’s Investment Network subscription, you’re missing out on a huge opportunity. Right now is your chance to grab one of the biggest (and most valuable) upgrades our company has ever made to a newsletter. I’m taking Altucher’s Investment Network to an entirely new level and I’d hate to see you left behind. [To see how to claim your upgrade, just click here now.]( Therefore, Ray says, this is the EXACT time you should be buying: “if history is any guide, buying biotech now should produce big gains in the months ahead.” Beyond just market cycles, the fundamentals are strong in biotech. “Last year,” says Ray, “the FDA granted 50 approvals for novel drugs, a near record that includes many first-in-class therapies. So far this year, the regulator has approved 16 more.” While innovation hasn’t slowed down — bear markets are for builders, after all — Ray keeps his eyes peeled for the BIG asymmetric bets. And there’s ONE company that’s got his interest. First of all, the company is tiny. Upon writing, the stock price is lower than $5 per share. And, Ray isn’t the only one excited about this opportunity. James is, too. So excited, in fact, James did something I’ve never seen him do. He made a video inviting YOU to come invest in this company alongside him. Fair warning: The invitation expires tonight. Don’t miss it. Before it’s too late… [Click here to watch James’ video.]( Until tomorrow, [Chris Campbell] Chris Campbell For Altucher Confidential Biden’s Plan to Confiscate Your Cash? [Click here for more...]( March 9, President Biden quietly signed Executive Order 14067. This Order could pave the way for Democrats holding onto power in 2024. In fact, they could control America indefinitely. A former advisor to the CIA and Pentagon believes this order could allow for legal government surveillance of all US citizens; total control over your bank accounts and purchases; and the ability to silence all dissenting voices for good. To protect your freedom and your wealth, [see his dark warning now.]( Subsribe To My Podcast [The James Altucher Show]( [The James Altucher Website]( [Subscribe With YouTube]( [Subscribe On Messenger]( [Subscribe With iTunes]( [Connected on LinkedIn]( Add AltucherConfidential@email.threefounderspublishing.com to your address book: [Whitelist Us]( Join the conversation! Follow me on social media: [Facebook Group]( [Facebook]( [Twitter]( [Pinterest]( [Instagram]( [Three founders Publishing]( To end your Altucher Confidential e-mail subscription and associated external offers sent from Altucher Confidential, feel free to [click here](. If you are having trouble receiving your Altucher Confidential subscription, you can ensure its arrival in your mailbox by [whitelisting Altucher Confidential](. Altucher Confidential is committed to protecting and respecting your privacy. Please read [our Privacy Statement.]( For any further comments or concerns please email us at AltucherConfidential@threefounderspublishing.com. Nothing in this e-mail should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. © 2022 Three Founders Publishing, LLC., 808 Saint Paul Street, Baltimore MD 21202. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Three Founders Publishing, LLC. EMAIL REFERENCE ID: 430ALCED01[.](